Peyrin-Biroulet L - Search Results

1

Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review.

Muller M, Broséus J, Feugier P, Thieblemont C, Beaugerie L, Danese S, Arnone D, Ndiaye NC, Kokten T, Houlgatte R, Peyrin-Biroulet L. Muller M, et al. J Crohns Colitis. 2021 May 4;15(5):827-839. doi: 10.1093/ecco-jcc/jjaa193. J Crohns Colitis. 2021. PMID: 32949235

2

Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.

Peyrin-Biroulet L, Rodriguez-Guéant RM, Chamaillard M, Desreumaux P, Xia B, Bronowicki JP, Bigard MA, Guéant JL. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2007 May;102(5):1108-15. doi: 10.1111/j.1572-0241.2007.01170.x. Epub 2007 Mar 13. Am J Gastroenterol. 2007. PMID: 17355415 Review.

3

Early combined immunosuppression in Crohn's disease.

Danese S, Peyrin-Biroulet L. Danese S, et al. Lancet. 2008 Jun 14;371(9629):1996; author reply 1996-7. doi: 10.1016/S0140-6736(08)60862-4. Lancet. 2008. PMID: 18555908 No abstract available.

4

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B. Roblin X, et al. Am J Gastroenterol. 2008 Dec;103(12):3115-22. doi: 10.1111/j.1572-0241.2008.01743.x. Am J Gastroenterol. 2008. Retraction in: Am J Gastroenterol. 2009 Mar;104(3):801. doi: 10.1038/ajg.2009.101 PMID: 19086961 Retracted. Clinical Trial.

5

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group. Beaugerie L, et al. Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7. Lancet. 2009. PMID: 19837455

6

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L. Chevaux JB, et al. Inflamm Bowel Dis. 2010 Jun;16(6):916-24. doi: 10.1002/ibd.21147. Inflamm Bowel Dis. 2010. PMID: 19885908

7

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.

Oussalah A, Danese S, Peyrin-Biroulet L. Oussalah A, et al. Curr Drug Targets. 2010 Feb;11(2):156-75. doi: 10.2174/138945010790309939. Curr Drug Targets. 2010. PMID: 20210765 Review.

8

Infliximab and azathioprine for Crohn's disease: a super-sonic combination?

Peyrin-Biroulet L, Danese S. Peyrin-Biroulet L, et al. Gastroenterology. 2010 Sep;139(3):1059-61. doi: 10.1053/j.gastro.2010.07.035. Epub 2010 Jul 24. Gastroenterology. 2010. PMID: 20659456 No abstract available.

9

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Chevaux JB, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Inflamm Bowel Dis. 2011. PMID: 20949566 Review.

10

Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.

Chowers Y, Sturm A, Sans M, Papadakis K, Gazouli M, Harbord M, Jahnel J, Mantzaris GJ, Meier J, Mottet C, Peyrin-Biroulet L, Allez M. Chowers Y, et al. J Crohns Colitis. 2010 Oct;4(4):367-76. doi: 10.1016/j.crohns.2010.05.011. Epub 2010 Jul 1. J Crohns Colitis. 2010. PMID: 21122531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,100 results

Search Page

Filters